111 related articles for article (PubMed ID: 1396987)
1. Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats.
De Sarro G; De Sarro A
Eur J Pharmacol; 1992 May; 215(2-3):221-9. PubMed ID: 1396987
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.
De Sarro GB; De Sarro A
Neuropharmacology; 1993 Jan; 32(1):51-8. PubMed ID: 8094234
[TBL] [Abstract][Full Text] [Related]
3. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
De Sarro G; De Sarro A; Ammendola D; Patel S
Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
Chapman AG; Graham JL; Patel S; Meldrum BS
Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.
De Sarro G; Di Paola ED; Aguglia U; de Sarro A
Pharmacol Biochem Behav; 1996 Sep; 55(1):39-48. PubMed ID: 8870036
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic anticonvulsant effects of D(-)CPPene in genetically epilepsy-prone rats.
Smith SE; Chapman AG
Epilepsy Res; 1993 Jul; 15(3):193-9. PubMed ID: 8223415
[TBL] [Abstract][Full Text] [Related]
7. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
8. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
[TBL] [Abstract][Full Text] [Related]
9. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.
Schmutz M; Portet C; Jeker A; Klebs K; Vassout A; Allgeier H; Heckendorn R; Fagg GE; Olpe HR; van Riezen H
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):61-6. PubMed ID: 1976233
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of D- and L-(E)-4-(3-phosphono-2-propenyl)piperazine-2-carboxylic acid as anticonvulsants and as inhibitors of potassium-evoked increases in hippocampal extracellular glutamate and aspartate levels in freely moving rats.
Millan MH; Chapman AG; Meldrum BS
J Neurochem; 1994 Jan; 62(1):217-22. PubMed ID: 7903351
[TBL] [Abstract][Full Text] [Related]
11. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.
De Sarro G; Renne S; Nava F; De Sarro A
J Pharm Pharmacol; 1994 Dec; 46(12):1017-22. PubMed ID: 7714713
[TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat.
Smith SE; al-Zubaidy ZA; Chapman AG; Meldrum BS
Epilepsy Res; 1993 Jun; 15(2):101-11. PubMed ID: 8103738
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy.
Patel S; Chapman AG; Graham JL; Meldrum BS; Frey P
Epilepsy Res; 1990; 7(1):3-10. PubMed ID: 2292244
[TBL] [Abstract][Full Text] [Related]
15. Noncompetitive and competitive NMDA antagonists exert anticonvulsant effects by actions on different sites within the neuronal network for audiogenic seizures.
Faingold CL; Randall ME; Naritoku DK; Boersma Anderson CA
Exp Neurol; 1993 Feb; 119(2):198-204. PubMed ID: 8432360
[TBL] [Abstract][Full Text] [Related]
16. Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation.
Riaz A; Faingold CL
Alcohol Clin Exp Res; 1994 Dec; 18(6):1456-62. PubMed ID: 7695044
[TBL] [Abstract][Full Text] [Related]
17. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
De Sarro G; Ammendola D; Nava F; De Sarro A
Brain Res; 1995 Feb; 671(1):131-40. PubMed ID: 7728525
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy-prone rats.
De Sarro G; Rizzo M; Spagnolo C; Gitto R; De Sarro A; Scotto G; Zappala M; Chimirri A
Pharmacol Biochem Behav; 1999 Aug; 63(4):621-7. PubMed ID: 10462191
[TBL] [Abstract][Full Text] [Related]
19. Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration.
Cotterell KL; Croucher MJ; Bradford HF
Eur J Pharmacol; 1992 Apr; 214(2-3):285-7. PubMed ID: 1355438
[TBL] [Abstract][Full Text] [Related]
20. Effects of the N-methyl-D-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity.
Brandt MR; Cummons TA; Potestio L; Sukoff SJ; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2005 Jun; 313(3):1379-86. PubMed ID: 15764736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
